Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07313436 · ClinicalTrials.gov registry record · NA

Extended Release Protein Dosing

A NA study of Nutrition, sponsored by VitaKey.

Recruiting
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT07313436 is a NA study of Nutrition that is actively recruiting participants, run by VitaKey. The registered enrollment target is 21 participants, below the 3,208-participant average among 22 other Nutrition trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07313436, a NA study of Nutrition, is actively recruiting participants, sponsored by VitaKey.

RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to determine the minimum dose required to elicit measurable elevation of plasma essential amino acid levels 12 hours after consuming VitaKey's extended release protein technology. The results of this study will be used to set a dose for future protein clinical studies.

Conditions Studied

Nutrition

Interventions

  • OTHER Control
  • OTHER Extended release nutritional protein
  • OTHER Negative Dose

Study Locations (1)

Illinois

  • Biofortis - Addison

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2025-11-17
Est. Completion 2026-04
Phase NA

Sponsor

VitaKey

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07313436

The ClinicalTrials.gov registry entry for NCT07313436 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,208-participant average among 22 other Nutrition trials with a reported enrollment target (99% lower). The listed sponsor is VitaKey, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nutrition appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT07313436 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07313436 about?

NCT07313436 is a clinical study titled "Extended Release Protein Dosing". The overall goal of this study is to determine the minimum dose required to elicit measurable elevation of plasma essential amino acid levels 12 hours after consuming VitaKey's extended release protein technology. The results of this study will be used to set a dose for future protein clinical studi...

What is the current status of trial NCT07313436?

This trial is currently recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2025-11-17. Estimated completion is 2026-04.

What conditions does trial NCT07313436 study?

This clinical trial studies the following conditions: Nutrition.

What interventions are being tested in trial NCT07313436?

The interventions under investigation include: Control (OTHER), Extended release nutritional protein (OTHER), Negative Dose (OTHER).

Who is sponsoring clinical trial NCT07313436?

This trial is sponsored by VitaKey, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07313436 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nutrition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nutrition

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.